Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
RVMD on Nasdaq
Shares outstanding
192,966,469
Price per share
$98.20
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
199,280,276
Total reported value
$15,873,982,580
% of total 13F portfolios
0.03%
Share change
+5,857,096
Value change
+$504,539,283
Number of holders
383
Price from insider filings
$98.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Farallon Capital Partners, L.P. 7.5% -5% $1,499,170,464 +$137,025,822 14,596,149 +10% Dapice Joshua J. 31 Dec 2025
JANUS HENDERSON GROUP PLC 6.1% +6.7% $530,327,722 +$35,740,771 11,356,054 +7.2% JANUS HENDERSON GROUP PLC 30 Sep 2025
BAKER BROS. ADVISORS LP 4.9% -2% $971,159,717 +$9,283,443 9,455,357 +0.97% Baker Bros. Advisors LP 31 Dec 2025
FMR LLC 5% $439,058,769 9,401,687 FMR LLC 30 Sep 2025
BlackRock, Inc. 4.5% $309,009,603 8,399,214 BlackRock, Inc. 30 Jun 2025
WELLINGTON MANAGEMENT GROUP LLP 3.6% -32% $717,700,402 -$336,077,288 6,987,639 -32% Wellington Management Group LLP 31 Dec 2025

As of 31 Dec 2025, 383 institutional investors reported holding 199,280,276 shares of Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD). This represents 103% of the company’s total 192,966,469 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 8.7% 16,719,886 +6.7% 0.02% $1,331,738,920
FARALLON CAPITAL MANAGEMENT LLC 7.6% 14,582,796 -0.29% 6.7% $1,161,519,701
JANUS HENDERSON GROUP PLC 6.4% 12,303,502 +8.3% 0.44% $980,035,989
BAKER BROS. ADVISORS LP 4.9% 9,455,357 0% 4.4% $753,119,185
BlackRock, Inc. 4.6% 8,926,656 +7.2% 0.01% $711,008,150
FMR LLC 4.5% 8,587,981 -8.7% 0.03% $684,032,699
Nextech Invest, Ltd. 3.9% 7,601,087 0% 59% $605,426,580
WELLINGTON MANAGEMENT GROUP LLP 3.6% 6,987,639 -29% 0.1% $556,565,446
Paradigm Biocapital Advisors LP 3.4% 6,644,403 +6.8% 14% $529,226,699
Bellevue Group AG 2.6% 5,005,719 -10% 7.6% $398,705,518
STATE STREET CORP 2.1% 4,109,290 -22% 0.01% $327,304,949
PRICE T ROWE ASSOCIATES INC /MD/ 1.8% 3,404,717 -12% 0.03% $271,186,000
BVF INC/IL 1.7% 3,356,782 -16% 9% $267,367,686
Alphabet Inc. 1.7% 3,345,102 -19% 10% $266,437,374
GEODE CAPITAL MANAGEMENT, LLC 1.6% 3,161,963 +0.52% 0.02% $251,911,578
UBS Group AG 1.6% 3,087,937 +184% 0.05% $245,954,181
DEERFIELD MANAGEMENT COMPANY, L.P. 1.5% 2,894,613 -21% 3% $230,555,925
WESTFIELD CAPITAL MANAGEMENT CO LP 1.5% 2,845,013 +13% 0.94% $226,605,319
GENERAL ATLANTIC, L.P. 1.5% 2,812,928 +14% 7.8% $224,049,715
Casdin Capital, LLC 1.3% 2,577,333 -2.6% 13% $205,284,573
Woodline Partners LP 1.3% 2,500,895 -14% 0.77% $199,196,287
GOLDMAN SACHS GROUP INC 1.3% 2,491,274 +238% 0.03% $198,429,974
NORGES BANK 1.3% 2,455,347 0.02% $195,568,389
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.1% 2,205,555 +197% 0.27% $175,672,456
T. Rowe Price Investment Management, Inc. 1.1% 2,200,376 -54% 0.11% $175,260,000

Institutional Holders of Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 199,280,276 $15,873,982,580 +$504,539,283 $79.65 383
2025 Q3 191,767,706 $8,955,119,353 +$87,454,891 $46.70 318
2025 Q2 190,726,235 $7,017,009,498 -$4,134,347 $36.79 305
2025 Q1 191,051,347 $6,776,444,446 -$111,943,197 $35.36 281
2024 Q4 193,048,484 $8,445,124,761 +$672,301,180 $43.74 278
2024 Q3 170,577,261 $7,735,337,873 +$69,484,732 $45.35 252
2024 Q2 168,410,110 $6,536,274,916 +$309,463,084 $38.81 221
2024 Q1 160,549,965 $5,174,502,235 +$41,971,613 $32.23 207
2023 Q4 159,991,814 $4,588,662,174 +$1,173,667,984 $28.68 183
2023 Q3 112,410,338 $3,111,480,815 +$13,449,543 $27.68 165
2023 Q2 111,960,439 $2,994,417,481 +$107,072,959 $26.75 138
2023 Q1 108,245,336 $2,343,498,970 +$420,665,649 $21.66 149
2022 Q4 88,251,337 $2,102,174,977 +$32,658,345 $23.82 133
2022 Q3 88,392,782 $1,743,047,001 +$233,806,685 $19.72 133
2022 Q2 76,461,750 $1,490,187,152 +$40,971,035 $19.49 125
2022 Q1 73,955,592 $1,885,584,241 +$15,751,102 $25.51 122
2021 Q4 73,332,089 $1,845,795,329 -$50,104,402 $25.17 113
2021 Q3 68,952,735 $1,896,915,710 +$49,809,012 $27.51 109
2021 Q2 70,364,140 $2,233,248,707 +$91,598,352 $31.74 127
2021 Q1 66,456,882 $3,048,913,145 +$424,322,383 $45.88 124
2020 Q4 57,426,011 $2,273,517,142 +$133,648,027 $39.59 118
2020 Q3 56,953,834 $1,981,075,717 +$339,721,674 $34.80 90
2020 Q2 46,886,789 $1,478,128,925 +$22,763,370 $31.57 73
2020 Q1 46,881,176 $1,025,119,285 +$1,024,845,284 $21.91 72